Schedule 13G ownership disclosure
Janux Therapeutics Inc
Common Stock · CUSIP: 47103J105
Event date: 2025-12-31
- Filing-level shares
- 5,350,453
- Percent of class
- 8.9%
- JANUS HENDERSON GROUP PLC
Shares: 5,350,453 · Class: 8.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001274173-26-000086
- Form type
- SCHEDULE 13G/A
- Filer
- JANUS HENDERSON GROUP PLC
- CIK
- CIK 1274173
- Filed
- Feb 17, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership